RxDoctor Payments Data

Ignacio Acevedo Sierra

General Practice · Manati, PRNPI 1407942212

Payments from drug & device makers

$3,319in general payments, 2019–2025

Across 109 payments — averaging $30.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$905
  • AbbVie$549
  • E.r. Squibb & Sons, L.L.C.$479
  • PBG Puerto Rico LLC$374
  • AstraZeneca$176
  • Merck$127
  • plus $710 from 13 others

What the payments were for

  • Food & beverage$3,319100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson27$905
AbbVie(2 entities)24$549
E.r. Squibb & Sons, L.L.C.8$479
PBG Puerto Rico LLC17$374
AstraZeneca6$176
Merck3$127
Medtronic2$115
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)2$110
Bayer1$78
Sanofi-aventis U.S. LLC4$76
Novartis3$66
Chiesi USA, Inc.4$60
Lilly USA, LLC1$58
Boehringer Ingelheim2$44
Biotronik Inc.1$24
Bayer Puerto Rico Inc.1$23
Amgen1$21
Eli Lilly Export S.A. Puerto Rico Branch1$19
Pfizer Pharmaceuticals LLC1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,319 in reported general payments places this provider in the 95th percentile of 3,586 general practice providers in Puerto Rico.

See all general practice providers in Puerto Rico

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban59$37,597
LantusInsulin Glargine,hum.Rec.Anlog169$14,191
SynthroidLevothyroxine Sodium187$11,921
TrulicityDulaglutide11$11,373
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate34$8,545
BrilintaTicagrelor11$8,277
Gabapentin822$5,441
Atorvastatin Calcium420$5,365
Lantus SolostarInsulin Glargine,hum.Rec.Anlog47$4,970
Sucralfate130$4,546
Humalog Kwikpen U-100Insulin Lispro23$4,006
HumalogInsulin Lispro40$3,470
Diclofenac Potassium71$3,469
Famotidine587$3,308
Hydralazine Hcl152$2,713

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Humalog, Humulin N$58$16,88875 claims
Sanofi-aventis U.S. LLCLantus$76$14,191169 claims
AbbVieSynthroid$549$11,921187 claims
AstraZenecaBrilinta$176$8,27711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,586 general practice providers in Puerto Rico.

Other general practice in Manati

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →